Trial Profile
Multicenter Phase II Study of Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Multiforme
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2023
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Astrocytoma; Glioblastoma
- Focus Therapeutic Use
- 06 Jun 2023 Primary endpoint has not been met (Overall Survival), as per Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 06 Jun 2023 Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 02 Apr 2019 Status changed from active, no longer recruiting to completed.